Dr. Rod L. Flynn

Get to Know Dr. Rod L. Flynn

 Surgical oncologist Dr. Rod Flynn joined The Christ Hospital in 2017, improving the treatment of abdominal malignancies with the hyperthermic intraperitoneal chemotherapy procedure, also known as HIPEC.

Flynn combines HIPEC with cytoreductive surgery, dramatically increasing survival rates for diseases such as peritoneal mesothelioma cancer. The combination treatment is available only at select mesothelioma specialty centers.

HIPEC has been proven to stop – or at least significantly delay – abdominal tumor recurrence while minimizing the often-troublesome side effects of traditional systemic chemotherapy.

Flynn, who was born at The Christ Hospital, helped develop the HIPEC program at the Cancer Treatment Centers of America facility in Philadelphia.

He also treats pancreatic, liver, bile duct and small and large intestinal cancers. He performs laparoscopic surgery and laparoscopic staging of intra-abdominal malignancies, and is trained in the complex Whipple procedure, used for certain types of pancreatic cancer.

Beyond traditional medicine, Flynn talks often about a holistic approach to treatment that goes beyond the tumor itself, taking care of the mind, body and spirit of each patient.

Specialties of Dr. Rod L. Flynn

• HIPEC procedure
• Cytoreductive surgery
• Peritoneal mesothelioma
• Minimally invasive surgery
• Pancreatic cancer
• Liver cancer
• Intestinal cancers
• Whipple procedure
• Laparoscopic surgery

Dr. Rod L. Flynn’s Experience and Medical Education

• The Christ Hospital
• Cancer Treatment Centers of America
• University of Pittsburgh Medical Center (Fellowship)
• Graduate Hospital (Residency)
• Allegheny University Hospital (Internship)
• University of Maryland School of Medicine (M.D.)

Awards and Certifications

• Board certified in surgery
• Ohio state medical license
• Pennsylvania state medical license

Publications of Dr. Rod L. Flynn

• Flynn, R.L. et al. (2019, November). Rare Presentation of Postsurgical Pyoderma Gangrenosum Presenting as Necrotizing Soft Tissue Infection. Advanced Skin Wound Care.